Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
What Happened: Wood reiterated her earlier point on the “profound application” of AI in the healthcare industry, comparing it to the implementation of the same in autonomous vehicles and humanoid robots.
She quoted Dr. Peter H. Diamandis, the founder of Abundance360 and XPRIZE, who highlighted Mass General Brigham research.
According to the researchers at Mass General Brigham, AI was not only able to estimate a person’s biological age, but also improve cancer survival outcomes predictions by just analyzing a facial photograph.
Thus, this marked another small milestone in using AI within the healthcare industry.
Full story available on Benzinga.com
Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
What Happened: Wood reiterated her earlier point on the “profound application” of AI in the healthcare industry, comparing it to the implementation of the same in autonomous vehicles and humanoid robots.
She quoted Dr. Peter H. Diamandis, the founder of Abundance360 and XPRIZE, who highlighted Mass General Brigham research.
According to the researchers at Mass General Brigham, AI was not only able to estimate a person’s biological age, but also improve cancer survival outcomes predictions by just analyzing a facial photograph.
Thus, this marked another small milestone in using AI within the healthcare industry.
Full story available on Benzinga.com
Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
What Happened: Wood reiterated her earlier point on the “profound application” of AI in the healthcare industry, comparing it to the implementation of the same in autonomous vehicles and humanoid robots.
She quoted Dr. Peter H. Diamandis, the founder of Abundance360 and XPRIZE, who highlighted Mass General Brigham research.
According to the researchers at Mass General Brigham, AI was not only able to estimate a person’s biological age, but also improve cancer survival outcomes predictions by just analyzing a facial photograph.
Thus, this marked another small milestone in using AI within the healthcare industry.
While autonomous vehicles and humanoid robots are likely to be the largest applications of AI in the next five to ten years, health care …Full story available on Benzinga.com Read MoreAI, Analyst Color, ARK Invest, artificial intelligence, cancer, Cathie Wood, Equities, healthcare, ILMN, Market Summary, Mass General Brigham, Multiomics, Nemo M Despot, News, Peter H. Diamandis, QQQ, SPY, TEM, TWST, TXG, Broad U.S. Equity ETFs, Futures, Markets, Analyst Ratings, ETFs, General, SPY, US78462F1030, ILMN, US4523271090, QQQ, US73935A1043, TEM, TXG, TWST, News, Analyst Color, Equities, Market Summary, Broad U.S. Equity ETFs, Futures, Markets, Analyst Ratings, ETFs, General, Benzinga Markets
